Onabotulinum toxin for Pelvic pain Philip Toozs-Hobson Consultant Urogynaecologist Birmingham UK.

Slides:



Advertisements
Similar presentations
Efferent Division: Autonomic and Somatic Motor Control
Advertisements

SAMUEL AGUAZIM (MD) AUTONOMIC NERVOUS SYSTEM PHARMACOLOGY.
Botulinum toxin for neuropathic bladder Amir Hooshang Vahedi MD - Physiatrist.
Jonah Murdock, MD PhD Mid Atlantic Urology Associates July 2011.
Non Acute Scrotal Swelling
Botox® for the overactive bladder -The evidence Philip Toozs-Hobson Consultant Urogynaecologist.
Botulinum toxin-A for overactive bladder and detrusor overactivity Douglas Tincello Professor of Urogynaecology Prolapse & Incontinence Group, University.
Nervous System Controlling your body’s movements and senses.
Urinary Incontinence Kieron Durkan GPST 1.
1 Copyright © 2014 Elsevier Inc. All rights reserved. Chapter 29 Lower Urinary Tract Dysfunction and the Nervous System Amit Batla and Jalesh N. Panicker.
NEW CONCEPTS AND TECHNIQUES and pursuing a career in urogynaecology
Understanding Urodynamics Kim Duggan, RNC. Understanding Urodynamics Urodynamics is a study that assess how the bladder and urethra are performing their.
Overactive Bladder: Diagnosis and Treatment Chase Kenyon Sovell, MD Urology Associates May 30 th, 2007 Pearls of Plumbing Seminar.
Figure 15.1 The ANS and Visceral Sensory Neurons.
Urinary incontinence in women October Changing clinical practice NICE guidelines are based on the best available evidence The Department of Health.
Urinary Incontinence Victoria Cook
Lower Urinary Tract Symptoms in Men
Nursing approaches for urgency and Urge Incontinence
AUTONOMIC NERVOUS SYSTEM The ANS is part of the efferent portion of the peripheral nervous system.
THE AUTONOMIC NERVOUS SYSTEM D. C. MIKULECKY PROFESSOR OF PHYSIOLOGY.
Urinary Incontinence in women. Urinary incontinence Stress – involuntary leakage of urine on effort, sneezing or coughing Urgency – involuntary leakage.
Prescribing information is available at this meeting 1 MODULE 2 IDENTIFICATION, SCREENING AND DIAGNOSIS DET 808.
Disability and Incontinence Patient assessment Patient management.
Nervous System Med 6573 Visceral Nervous System Urinary Bladder Control / Referred Pain.
LUTS Shawket Alkhayal Consultant Urological Surgeon Benenden Hospital Tunbridge Wells Nuffield Hospital.
Case Studies in Neurological Rehabilitation Botulinum toxin for neuropathic bladder Alireza Ashraf, M.D. Professor of Physical Medicine & Rehabilitation.
Function of Ureter and Urinary Bladder
Pages Central Nervous System (brain and spinal cord) Peripheral Nervous System (cranial and spinal nerves) Somatic (voluntary) Autonomic (involuntary)
GERIATRICS : UI Dr. Meg-angela Christi Amores. URINARY INCONTINENCE  major problem for older adults, afflicting up to 30% of community-dwelling elders.
Physiology of micturition
 Stephen T Jeffery University of Cape Town, South Africa Urogynaecology and laparoscopy clinic
Keeping the right patients away from hospital
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Comments for Anatomy, Physiology and Urodynamics Hann-Chorng Kuo Department of Urology Buddhist Tzu Chi General Hospital.
Slide 1 Copyright © 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 13 Drugs Affecting the Autonomic Nervous System.
Sharon English Urologist Christchurch
Case Study in Chronic Pelvic Pain Jennifer McDonald DO F.A.C.O.G.
ROLE OF PERCUTANEOUS TIBIAL NERVE STIMULATION (PTNS) IN THE TREATMENT OF NEUROGENIC OVERACTIVE BLADDER SYNDROME Perugia G., Corongiu E., Borgoni.
Back to Basics A&P NZCA September 16, URETHRAL RESISTANCE Smooth muscle Striated muscle External urethral sphincter Pelvic floor muscles Mucosal.
Over active bladder drug treatment Mark Weatherall University of Otago Wellington.
Complications of Incontinence Management
Chronic Pelvic Pain in Primary Care
Anal Fissure Pharmacology
The Autonomic Nervous System
Copyright © 2008 Pearson Education, Inc., publishing as Pearson Benjamin Cummings In vertebrates – The CNS is composed of the brain and spinal cord – The.
Homeostasis maintaining a constant internal environment despite changes in external environment.
Dr. Salwan Al-Salihi UroGynaecologist and pelvic floor surgeon Obstetrician and Gynaecologist, Website: * Suite.
Women’s Health Kate Brocklehurst 17/07/2013. What we will cover What we’ve got and how it works What goes wrong? Terminology Women’s health assessment.
The autonomic nervous system Anatomic organization of the nervous system Nervous system Central nervous system Enclosed in bony cavities (skull, vertebral.
URINARY INCONTINENCE Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara.
Botox® - Frequently Asked Questions Presented by: Dr. Suresh Koneru Advanced Concepts in Plastic Surgery Named by his peers to the Super.
Interna tional Neurourology Journal 2010;14:26-33 Predictors of Postoperative Voiding Dysfunction following Transobsturator Sling Procedures in Patients.
OAB / LUTS Urology Pathway for Primary Care within Frimley Health locality Developed with key local stakeholders including Urologists, Gynaecologists,
Male Pelvic pain “Prostatitis and Levator Ani Syndrome
Urinary Incontinence A Practical Approach.
Retention of Urine Acute or Chronic.
Innervation and Function of the Female Urinary Bladder and Urethra
Urinary Symptoms in the Female
Predictors of Longterm Sacral Nerve Stimulation Failures
6.5 Neurons & Synapses.
6.5 Neurons & Synapses.
Micturition Domina Petric, MD.
Bladder Dysfunction Associated With Parkinson’s Disease
Pelvic floor dysfunction
Cholinergic Antagonist
6.5 Neurons & Synapses.
Initial Office Evaluation
Understanding the Role of Botulinum Toxin A in the Treatment of the Overactive Bladder—More than Just Muscle Relaxation  Apostolos Apostolidis, Axel Haferkamp,
Autonomic Nervous System (ANS)
Women’s & Men’s Health Physiotherapy
Presentation transcript:

Onabotulinum toxin for Pelvic pain Philip Toozs-Hobson Consultant Urogynaecologist Birmingham UK

Declaration I was sponsored by Allergan to travel to and attend this meeting I work as a consultant for Allergan and Astellas I was an author on the RELAX study I have been involved in Allergan and Astellas sponsored trials I undertake private practice

Onabotulinum Toxin Growing body of evidence Mainly case reports – Relatively rare Difficult to classify for research

What can you use Botox for… Ophthalmic – Strabismus – Blepherospasm MSK – Corticollis – Cervical dystonia Cosmetic Neurological – Migraines – severe primary axillary hyperhidrosis Urological – NDO/UDO

Botox and pain Torticollis Vulvodynia Back pain Fibromyalgia Tennis elbow Post mastectomy pain TMJ pain Chronic prostatic pain Whiplash Tendonitis Premature ejaculation Anal fissures

Mechanism of action

Facts Botox takes min 48 hours to get flaccid paralysis Pain relief almost instantaneous Botox migrates up nerves

Muscle contraction Peripheral sensitisation Central sensitisation BOTOX ® : An innovative treatment for OAB with a dual mechanism of action 1–3 Blocks peripheral release of neurotransmitter at presynaptic cholinergic nerve terminals Blocks release of neurotransmitters and down regulates expression of receptors associated with sensory afferent pathway BOTOX ® Targets both the efferent and afferent pathway Treatment benefit: Detrusor muscle relaxation Treatment benefit: Reduced urgency BOTOX ® targets both the afferent and efferent pathways Acetylcholine Sensory neuropeptides and receptors Sympathetic nervous system activity maintained as bladder fills Reduced parasympathetic nervous system activity in response to bladder distension Efferent pathway Afferent pathway OAB, overactive bladder. 1. BOTOX ® Summary of Product Characteristics, Allergan 2. Purves D, et al. Autonomic Regulation of the Bladder. Neuroscience. 2nd edition Apostolidis A, et al. Eur Urol 2006;49:644–50.

Site of action NMJ Autonomic ganglion Postganglionic parasympathetic nerve ending Postganglionic sympathetic nerve endings which use Ach

Nerve interactions

Differential diagnosis Vulvadynia Atrophic vaginitis PNE – After vaginal surgery Interstitial cystitis Visceral hypersensitivity Chronic Pelvic pain Fibromyalgia MS Vaginismus Myofascial trigger points Sacro-iliac joint pain Psoas problems Faccet joint problems Referred hip pain

Assessment History – Onset – Try to differentiate cause in history Examination – Pain mapping Treatment – Relaxation/PFE’s

Technique Pain map with patient awake GA 100U split doses into trigger points – Using pudendal needle Can do in outpatients in the brave – Using blue or green needles

A prospective cohort study 12 women dyspareunia (80 vs 28; P = 0.01) non-significant reductions in non-menstrual pelvic pain (64 vs 37) Pelvic floor muscles manometry showed a 37% reduction in resting pressure Jarvis et al ANZJOG 2004

Largest review >400 patients four subgroups: BPS/IC (n = 157) CPP (n = 98), vulvodynia dyspareunia (n = 40) “other” (n = 113). complaints of voiding dysfunction (70%), dyspareunia (54%) mean PUF score of 15.9 ± 6.4 positive potassium sensitivity test in 83%. Urodynamics revealed a maximal urethral pressure of 131 cm of water and an abnormal uroflow in 80%. benefit in all groups (50%, 67%, 73%, and 77% for vulvodynia, CPP, BPS/IC, “other”). International Urogynecology Journal Volume 20, Number 9 (2009), , Volume 20, Number 9

Our results Have treated around 30 patients About a 70% response rate Lasts at least 6 months – Side effects: urinary incontinence, retention, faecal incontinence

Refractoy Myofascial trigger points Methods 31 patients ( ) mainly 300 U Mean age 55 Median pain 9.5/10 – 15 repeat injections (at median of 4 months) 17 OPD treatment Results 52% pain free Median score 3/10 Side effects – Urinary retention (3) – faecal incont (2) – Constipation/pain (3) But improved in 15! Adelowo et al Female Pelvic Med Reconstructr surg 2013

Conclusions Increasing understanding of Mechanisms of action of Botox Increasing data on safety Can be very useful with careful patient selection